A useful approach to control is to avoid risk factors outlined under epidemiology above. Vaccination is probably the most widely used tool in control however.
A recent Veterinary Record paper by leading expert Dr W A Ellis has reviewed the situation regarding control of leptospirosis. In this paper it was stated - “... it is safe to conclude that serovars Icterohaemorrhagiae and Canicola should continue to be included in dog vaccines in Europe. In addition, there is a good case for the inclusion of serovar Bratislava in vaccines, and, in the case of mainland Europe (but not in the UK), for serovar Grippotyphosa to be included as well.”
MSD Animal Health has recently introduced to the Irish market the first canine leptospirosis vaccine to include serovars from all four key serogroups in Ireland, the UK and continental Europe, with specific claims against:
Serovar Copenhageni (Serogroup Icterohaemorrhagiae)
Serovar Canicola (Serogroup Canicola)
Serovar Bratislava (Serogroup Australis)
Serovar Dadas (Serogroup Grippotyphosa)
Typically cross-protection provided by leptospirosis vaccines against specific serovars may be demonstrated by a combination of challenge trials and serological assessment.
Further studies carried out with this vaccine and serovars Icterohaemorrhagiae and Grippotyphosa suggest that the new vaccine is likely to cross-immunise against these serovars too.
This vaccine may only be prescribed by your veterinary practitioner from whom advice must be sought. For further information on disease and vaccination please click here.